[go: up one dir, main page]

DE69713284D1 - Triazol-Derivate als Arzneimittel - Google Patents

Triazol-Derivate als Arzneimittel

Info

Publication number
DE69713284D1
DE69713284D1 DE69713284T DE69713284T DE69713284D1 DE 69713284 D1 DE69713284 D1 DE 69713284D1 DE 69713284 T DE69713284 T DE 69713284T DE 69713284 T DE69713284 T DE 69713284T DE 69713284 D1 DE69713284 D1 DE 69713284D1
Authority
DE
Germany
Prior art keywords
medicines
triazole derivatives
triazole
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69713284T
Other languages
English (en)
Other versions
DE69713284T2 (de
Inventor
W Murtiashaw
Stuart Green
T Stephenson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd Great Britain
Pfizer Research and Development Co NV SA
Original Assignee
Pfizer Ltd Great Britain
Pfizer Research and Development Co NV SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd Great Britain, Pfizer Research and Development Co NV SA filed Critical Pfizer Ltd Great Britain
Application granted granted Critical
Publication of DE69713284D1 publication Critical patent/DE69713284D1/de
Publication of DE69713284T2 publication Critical patent/DE69713284T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6515Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having three nitrogen atoms as the only ring hetero atoms
    • C07F9/6518Five-membered rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69713284T 1996-02-02 1997-01-27 Triazol-Derivate als Arzneimittel Expired - Fee Related DE69713284T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9602080.5A GB9602080D0 (en) 1996-02-02 1996-02-02 Pharmaceutical compounds
PCT/EP1997/000445 WO1997028169A1 (en) 1996-02-02 1997-01-27 Triazole derivatives useful in therapy

Publications (2)

Publication Number Publication Date
DE69713284D1 true DE69713284D1 (de) 2002-07-18
DE69713284T2 DE69713284T2 (de) 2003-03-27

Family

ID=10787975

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69713284T Expired - Fee Related DE69713284T2 (de) 1996-02-02 1997-01-27 Triazol-Derivate als Arzneimittel

Country Status (42)

Country Link
US (4) US6790957B2 (de)
EP (1) EP0880533B1 (de)
JP (1) JP2959846B2 (de)
KR (1) KR100283546B1 (de)
CN (1) CN1085213C (de)
AP (1) AP678A (de)
AT (1) ATE219089T1 (de)
AU (1) AU709781B2 (de)
BG (1) BG63946B1 (de)
BR (1) BR9707257A (de)
CA (1) CA2240777C (de)
CO (1) CO4761066A1 (de)
CZ (1) CZ291431B6 (de)
DE (1) DE69713284T2 (de)
DK (1) DK0880533T3 (de)
DZ (1) DZ2172A1 (de)
ES (1) ES2175336T3 (de)
GB (1) GB9602080D0 (de)
GT (1) GT199700016A (de)
HN (1) HN1997000012A (de)
HR (1) HRP970063B1 (de)
HU (1) HU226133B1 (de)
ID (1) ID15858A (de)
IL (3) IL124865A (de)
IS (1) IS1995B (de)
MY (1) MY116849A (de)
NO (1) NO323771B1 (de)
NZ (1) NZ330654A (de)
OA (1) OA10711A (de)
PL (1) PL187237B1 (de)
PT (1) PT880533E (de)
RS (1) RS49526B (de)
RU (1) RU2176244C2 (de)
SA (1) SA97170578B1 (de)
SI (1) SI0880533T1 (de)
SK (1) SK283136B6 (de)
TN (1) TNSN97023A1 (de)
TR (1) TR199801440T2 (de)
TW (1) TW434247B (de)
UA (1) UA46828C2 (de)
WO (1) WO1997028169A1 (de)
ZA (1) ZA97826B (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9602080D0 (en) * 1996-02-02 1996-04-03 Pfizer Ltd Pharmaceutical compounds
GB9713149D0 (en) 1997-06-21 1997-08-27 Pfizer Ltd Pharmaceutical formulations
DE19751525C2 (de) 1997-11-20 2003-02-13 Bat Cigarettenfab Gmbh Verfahren und Vorrichtung zur Regelung der Ausgangsfeuchte von Tabak
US6265584B1 (en) 1998-05-22 2001-07-24 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
WO2000030655A1 (en) 1998-11-20 2000-06-02 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
US6235728B1 (en) 1999-02-19 2001-05-22 Bristol-Myers Squibb Company Water-soluble prodrugs of azole compounds
KR20010050557A (ko) 1999-09-29 2001-06-15 타이도 나오카타 아졸 유도체 또는 그의 염
US6362172B2 (en) * 2000-01-20 2002-03-26 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
US6448401B1 (en) * 2000-11-20 2002-09-10 Bristol-Myers Squibb Company Process for water soluble azole compounds
US7540402B2 (en) * 2001-06-29 2009-06-02 Kva, Inc. Method for controlling weld metal microstructure using localized controlled cooling of seam-welded joints
US7323572B2 (en) 2002-07-16 2008-01-29 Pfizer Inc Process for controlling the hydrate mix of a compound
WO2005006860A2 (en) * 2003-07-18 2005-01-27 The Board Of Governors For Higher Education State Of Rhode Island And Providence Plantations Azole derivatives and methods for making the same
KR20070085093A (ko) * 2004-03-24 2007-08-27 파스젠, 엘엘씨. Amp-활성화 단백질 키나아제의 약리학적 저해에 의한신규한 신경 보호 방법
CN1303073C (zh) * 2005-05-31 2007-03-07 中国人民解放军第二军医大学 取代三唑酮苄胺三唑醇类抗真菌化合物及其制备方法
ES2432360T3 (es) * 2005-12-20 2013-12-03 Eisai R&D Management Co., Ltd. Procedimiento para la producción de profármaco de azol soluble en agua
ES2533007T3 (es) 2005-12-27 2015-04-06 Otsuka Pharmaceutical Co., Ltd. Compuesto de benzoacepina soluble en agua y su composición farmacéutica
ES2351365T3 (es) * 2006-02-22 2011-02-03 EISAI R&D MANAGEMENT CO., LTD. Composición farmacéutica estabilizada.
KR100889937B1 (ko) * 2007-08-06 2009-03-20 한미약품 주식회사 보리코나졸의 제조방법
US20110123627A1 (en) * 2008-04-15 2011-05-26 Larry Yun Fang High density compositions containing posaconazole and formulations comprising the same
CN101575330B (zh) * 2008-05-05 2012-10-31 丽珠医药集团股份有限公司 伏立康唑广谱抗真菌药物化合物、其组合物及用途
WO2011064558A2 (en) 2009-11-30 2011-06-03 Cipla Limited Pharmaceutical composition
EP2723452A2 (de) 2011-06-22 2014-04-30 Vyome Biosciences Pvt Ltd Konjugatbasierte antimykotische und antibakterielle prodrugs
EP2561863A1 (de) 2011-08-22 2013-02-27 Farmaprojects, S.A.U. Pharmazeutische Zusammensetzungen mit Voriconazol
ES2774267T3 (es) * 2012-01-20 2020-07-20 Mycovia Pharmaceuticals Inc Compuestos inhibidores de metaloenzimas
SMT202300324T1 (it) * 2012-03-19 2023-11-13 Cidara Therapeutics Inc Regimi di dosaggio per composti della classe delle echinocandine
CN103864844B (zh) * 2012-12-09 2016-10-05 正大天晴药业集团股份有限公司 一种福司氟康唑的制备方法
CN103304600B (zh) * 2013-03-04 2018-05-25 陕西合成药业股份有限公司 一种伏立康唑磷酸酯三水合物及其制备方法和用途
US20140275122A1 (en) 2013-03-14 2014-09-18 Fresenius Kabi Usa, Llc Voriconazole Formulations
RU2719579C2 (ru) * 2013-03-14 2020-04-21 Сидара Терапьютикс, Инк. Режимы дозирования для соединений класса эхинокандинов
MX2015016675A (es) 2013-06-04 2016-07-15 Vyome Biosciences Pvt Ltd Particulas recubiertas y composiciones que comprenden las mismas.
CN103524560A (zh) * 2013-09-28 2014-01-22 陕西合成药业有限公司 伏立康磷酸酯钠水合物及其多晶型
CN104650140B (zh) * 2013-11-18 2017-11-10 正大天晴药业集团股份有限公司 一种高纯度福司氟康唑的制备方法
AU2015212312A1 (en) 2014-01-29 2016-08-18 Vyome Therapeutics Limited Treatments for resistant acne
CN104860992A (zh) * 2014-02-25 2015-08-26 陕西合成药业股份有限公司 一种高纯度福司氟康唑制备方法
CN105985377A (zh) * 2015-02-09 2016-10-05 陕西合成药业股份有限公司 一种福司氟康唑盐水合物及其制备方法
CN106279280A (zh) * 2015-05-25 2017-01-04 西藏卫信康医药股份有限公司 一种化合物及其制备方法和应用
CN106518922A (zh) * 2015-09-12 2017-03-22 陕西合成药业股份有限公司 一种三唑类化合物及其制备方法和用途
CN106546668A (zh) * 2015-09-22 2017-03-29 陕西合成药业股份有限公司 一种分离福司氟康唑或其药用盐有关物质的hplc方法
CN105237569B (zh) * 2015-10-21 2017-07-25 西南科技大学 一种制备2,4‑二氟‑α,α‑二(1氢‑1,2,4‑三唑‑1‑基甲基)苯甲醇磷酸二苄酯的合成方法
CN105753902B (zh) * 2016-04-11 2017-08-25 浙江诚意药业股份有限公司 一种福司氟康唑的制备方法
CN108676031A (zh) * 2018-05-29 2018-10-19 重庆威鹏药业有限公司 水溶性三唑类抗真菌膦酸化合物及其制备方法和应用
CN111171075B (zh) * 2020-04-03 2022-07-12 北京四环生物制药有限公司 一种福司氟康唑的制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2099818A (en) * 1981-06-06 1982-12-15 Pfizer Ltd Triazoles
US4528284A (en) * 1982-10-15 1985-07-09 Ciba-Geigy Corporation Fungicidal 2-(azolylmethyl-1'-yl)-2-aryl-2-(cyano, alkoxycarbonyl, alkylthiocarbonyl and aminocarbonyl)-2-phosphorus acid esters
US4952232A (en) * 1987-04-29 1990-08-28 E. I. Du Pont De Nemours And Company Antifungal carbinols
US5043273A (en) * 1989-08-17 1991-08-27 Monsanto Company Phosphorylated glycosidase inhibitor prodrugs
GB9002375D0 (en) * 1990-02-02 1990-04-04 Pfizer Ltd Triazole antifungal agents
US5278175A (en) * 1990-02-02 1994-01-11 Pfizer Inc. Triazole antifungal agents
TW211006B (de) * 1990-08-24 1993-08-11 Mochida Pharm Co Ltd
TW218017B (de) * 1992-04-28 1993-12-21 Takeda Pharm Industry Co Ltd
US5358939A (en) * 1992-06-25 1994-10-25 Rohm And Haas Company Fungicidal 2-aryl-2,2-disubstituted ethyl-1,2,4-triazoles
WO1995019983A1 (en) * 1994-01-24 1995-07-27 Janssen Pharmaceutica N.V. Watersoluble azole antifungals
NZ270418A (en) * 1994-02-07 1997-09-22 Eisai Co Ltd Polycyclic triazole & imidazole derivatives, antifungal compositions
AU682580B2 (en) * 1994-02-25 1997-10-09 Takeda Chemical Industries Ltd. Injectable emulsions containing antifungal triazole derivatives
GB9512961D0 (en) * 1995-06-26 1995-08-30 Pfizer Ltd Antifungal agents
FR2741061B1 (fr) * 1995-11-13 1998-03-20 Alcatel Fibres Optiques Procede de fabrication d'une fibre optique monomode et amplificateur optique utilisant une telle fibre
GB9602080D0 (en) * 1996-02-02 1996-04-03 Pfizer Ltd Pharmaceutical compounds
US5767977A (en) * 1996-12-19 1998-06-16 Hewlett-Packard Co. Method and apparatus for a carriage latch and power cord lock-out system for an optical scanner

Also Published As

Publication number Publication date
SK283136B6 (sk) 2003-03-04
DK0880533T3 (da) 2002-07-15
BG63946B1 (bg) 2003-07-31
HK1018217A1 (en) 1999-12-17
PT880533E (pt) 2002-09-30
HRP970063A2 (en) 1998-06-30
ID15858A (id) 1997-08-14
YU2997A (sh) 2000-10-30
DE69713284T2 (de) 2003-03-27
KR19990082233A (ko) 1999-11-25
CN1210540A (zh) 1999-03-10
OA10711A (en) 2001-06-04
WO1997028169A1 (en) 1997-08-07
US20040236105A1 (en) 2004-11-25
UA46828C2 (uk) 2002-06-17
RU2176244C2 (ru) 2001-11-27
PL187237B1 (pl) 2004-06-30
IL124865A (en) 2002-03-10
HUP9900949A3 (en) 2001-08-28
RS49526B (sr) 2006-12-15
US20050130940A1 (en) 2005-06-16
JPH10512599A (ja) 1998-12-02
AP9700923A0 (en) 1997-01-31
TR199801440T2 (xx) 1998-10-21
DZ2172A1 (fr) 2002-12-01
PL328436A1 (en) 1999-02-01
BR9707257A (pt) 1999-04-06
CA2240777C (en) 2002-06-11
JP2959846B2 (ja) 1999-10-06
SI0880533T1 (en) 2002-08-31
GT199700016A (es) 1998-07-24
HUP9900949A2 (hu) 2001-05-28
IL133135A0 (en) 2001-03-19
CZ242098A3 (cs) 1999-05-12
EP0880533A1 (de) 1998-12-02
ZA97826B (en) 1998-07-31
CZ291431B6 (cs) 2003-03-12
US20070027115A1 (en) 2007-02-01
IS4785A (is) 1998-06-26
NO983560L (no) 1998-08-03
ES2175336T3 (es) 2002-11-16
KR100283546B1 (ko) 2001-04-02
TNSN97023A1 (fr) 2005-03-15
CN1085213C (zh) 2002-05-22
HRP970063B1 (en) 2001-12-31
IL133135A (en) 2003-07-06
TW434247B (en) 2001-05-16
BG102603A (en) 1999-03-31
AU709781B2 (en) 1999-09-09
EP0880533B1 (de) 2002-06-12
MY116849A (en) 2004-04-30
HN1997000012A (es) 1997-06-26
HU226133B1 (en) 2008-05-28
IL124865A0 (en) 1999-01-26
SA97170578B1 (ar) 2006-01-28
IS1995B (is) 2005-03-15
CA2240777A1 (en) 1997-08-07
US6977302B2 (en) 2005-12-20
AU1598597A (en) 1997-08-22
NO323771B1 (no) 2007-07-02
ATE219089T1 (de) 2002-06-15
SK102298A3 (en) 1999-08-06
US20030144250A1 (en) 2003-07-31
NO983560D0 (no) 1998-08-03
NZ330654A (en) 1999-08-30
US6790957B2 (en) 2004-09-14
GB9602080D0 (en) 1996-04-03
AP678A (en) 1998-09-28
CO4761066A1 (es) 1999-04-27

Similar Documents

Publication Publication Date Title
DE69713284D1 (de) Triazol-Derivate als Arzneimittel
ATE367150T1 (de) Arzneimittel
ATE187063T1 (de) Arzneimittel
FI971234A7 (fi) Imidatsolijohdannainen
DE69629755D1 (de) Irbesartanhaltiges Arzneimittel
EE9900211A (et) Asendatud pürasooliderivaadid
DE69611361D1 (de) Chinazolin-derivate
DE69908021D1 (de) Ziprasidonhaltige Arzneimittel
NO974103L (no) Arylsulfonylaminohydroksamsyre-derivater
TR199501463A2 (tr) Triazolil türevleri.
DE69610698D1 (de) Chinazolin-derivate
ATE323682T1 (de) Aryl-pyrimidin-derivate
ATE261942T1 (de) 6-phenylpyridinderivate
ATE199150T1 (de) Diphenylmethylenpiperidin-derivate
NO964667D0 (no) Purin-6-on-derivater
DE69732576D1 (de) Tetrahydrobenzindolon-derivate
DE69601527D1 (de) Pyrrolylbenzimidazol-Derivate
IS5026A (is) 2-metoxýfenýlpíperasín afleiður
ATE240307T1 (de) Diarylalkenylamin-derivate
ATE239018T1 (de) Pyrazol-derivate
ATE269337T1 (de) Trizyclische delta3-pyridine als arzneimittel
DE59607054D1 (de) 4-Amino-benzoylguanidin-Derivate
ATE177102T1 (de) Chromanderivate
DK0843675T3 (da) Aza-anthracyclinonderivater
DE59607055D1 (de) 4-Mercapto-benzoylguanidin-Derivate

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee